Tokyo, Japan

Mitsura Tanemura

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsura Tanemura. Retrieved from https://idiyas.com/inventor/mitsura-tanemura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mitsura Tanemura: Innovator in Anti-Peptic Ulcer Agents

Introduction

Mitsura Tanemura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-peptic ulcer agents. His work has the potential to improve the quality of life for many individuals suffering from peptic ulcers.

Latest Patents

Tanemura holds a patent for an anti-peptic ulcer agent that contains aminobenzoic acid compounds as its active ingredient. The patent describes a method for preventing or treating individuals in need of such intervention by administering an effective amount of the active ingredient. This innovative approach highlights the importance of his research in addressing gastrointestinal health issues.

Career Highlights

Throughout his career, Mitsura Tanemura has been associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work there has allowed him to focus on developing effective treatments for various medical conditions, showcasing his dedication to advancing healthcare solutions.

Collaborations

Tanemura has collaborated with esteemed colleagues, including Tamotsu Yamazaki and Koji Mizuno. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Mitsura Tanemura's contributions to the development of anti-peptic ulcer agents exemplify his commitment to improving healthcare. His innovative work continues to have a lasting impact on the pharmaceutical industry and the lives of patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…